Corante

About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

GUEST AUTHOR ARCHIVES
THE NEURO REVOLUTION
TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Tel Aviv Neurotech Cluster Thrives | Main | The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics »

February 1, 2010

Neuropharma FDA Approvals Down in 2009

Email This Entry

Posted by Zack Lynch

200_Neurosurgery-Cover.jpgAs we report today in this month's edition of Neurotech Insights, five of the 26 new drugs and biologics approved by the FDA were neuropharmaceuticals: Vanda/Novartis’ Fanapt for schizophrenia, Lundbeck's Sabril for infantile spasms and add-on for refractory partial seizures, Cypress/Forest’s Savella for fibromyalgia, Merck's (Organon) Saphris for bipolar and schizophrenia, and Novartis’ branded version of betaseron for multiple sclerosis.. This compares to seven neuropharmaceutical approvals out of 24 in 2008 (Pristiq, Relistor, Entereg, Xenazine, Vimpat, Banzel and tapentadol) and only two of 17 in 2007.

Comments (0) + TrackBacks (0) | Category: Neuropharma


POST A COMMENT

Thanks for signing in, . Now you can comment. (sign out)

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)





Remember me?


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20
Giving the Brain a Voice: NIO Public Policy Tour in DC tomorrow
McGovern Institue for Brain Research at MIT Goes Web 2.0
The Neurodiagnostics Report 2010: Brain Imaging, Biomarkers and NeuroInformatics
Neuropharma FDA Approvals Down in 2009
Tel Aviv Neurotech Cluster Thrives